May 13, 2019 Update: The working group recommendations regarding the Cuvitru brand shortage are available here.

Subcutaneous immune globulin (SCIG) is a blood product licensed in Canada for the treatment of patients with primary immunodeficiency disease. Unlike IVIG, which is infused in a hospital, SCIG can be infused at home by a patient who has been trained.

This section provides templates for health authorities to develop and customize their own SCIG program. 



SCIG Resource Kit

SCIG Resource Kit Cover Sheet

Under Review 

Provincial Guidelines for SCIG Home Infusion Programs

Under Review 
 Training Materials  

Teaching Plan

 Under Review

Patient Post-Training Quiz


Patient Skills Assessment


Patient Evaluation of Training


Pre-Training Letter to GP

Under Review 

Post-Training Letter to GP

 Under Review
Patient Handouts

Patient Brochure

 Under Review

Patient Handbook


Quick Reference Guide: How to draw SCIG into a syringe

Under Review 

Infusion Log

Form and Letter Templates

Patient Referral Form

Under Review 

Patient Consent and Participation Agreement 


Patient Intake Form 


SCIG Patient Enrolment Form - Gamunex 


SCIG Patient Enrolment Form - Hizentra


SCIG Product Order / Pick-up Form - Gamunex 


SCIG Product Order / Pick-up Form - Hizentra


Travel Letter - Gamunex


Travel Letter - Hizentra